U.S.-Japan Technology Linkages in Biotechnology Challenges for the 1990s (1992) / Chapter Skim
Currently Skimming:
1. INTRODUCTION
1. INTRODUCTION
Pages 1-4
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 1... ...
Dibner and R Steven White, "Biotechnology in the United States and Japan: Who's First?
|
From page 2... ...
We are moving toward a global economy, and the desires of large Japanese companies, both pharmaceutical companies and ones doing business in unrelated fields, to access technology developed in the United States and to compete globally are important contributing factors. Japanese firms see biotechnology as a way to use scarce resources to improve their productivity and international competitiveness.
|
From page 3... ...
biotechnology firms or larger companies, it may be possible or even necessary to ensure corporate growth (and possibly survival) by linking up with Japanese companies in joint ventures or other agreements that give the Japanese partners rights to license and market technologies and products that were developed in the United States.
|
From page 4... ...
Steven Burrill of Ernst & Young, the working group was formed in the fall of 1990 and met a number of times in 1991 to deliberate and confer on the data collection process. A workshop on U.S.-Japan Technology Linkages in Biotechnology was convened in June 1991 to gain additional insights from other experts in the United States and Japan.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.